Plotch S J, Tomasz J, Krug R M
J Virol. 1978 Oct;28(1):75-83. doi: 10.1128/JVI.28.1.75-83.1978.
In the presence of Mg(2+) and a specific dinucleotide primer (ApG or GpG), the influenza virion transcriptase synthesizes the eight discrete segments of complementary RNA (cRNA) containing polyadenylic acid (Plotch and Krug, J. Virol. 21:24-34, 1977). Virions were examined for their ability to cap and methylate cRNA containing di- or triphosphorylated 5' termini. By using the primers ppApG, pppApG, or ppGpG, viral cRNA was synthesized in vitro with [alpha-(32)P]-GTP and S-[methyl-(3)H]adenosylmethionine as labeled precursors. DEAE-Sephadex chromatography of the RNase T2 digest of the cRNA product demonstrated no (3)H incorporation at all and the absence of a (32)P-labeled cap structure. The 5' terminus of ppApG-primed cRNA could be capped and methylated by enzymes from vaccinia virus, indicating that the two 5'-terminal phosphates derived from the primer were preserved in the product cRNA. The cap structure formed by the vaccinia enzymes and released by RNase T2 digestion as m(7)GpppA(m)pGp was radioactively labeled at its 3'-terminal phosphate only when [alpha-(32)P]CTP was used as the labeled precursor during transcription. This indicates that the 5'-terminal sequence of the cRNA is ppApGpC and that, therefore, ppApG most probably initiates transcription exactly at the 3' GpCpU(OH) terminus of the virion RNA templates. Virions were also tested for their ability to cap and methylate ppApG in the absence of transcription. No such activities were detected, whereas under the same conditions the vaccinia virus enzymes successfully capped and methylated this compound. Consequently, these experiments, together with those reported earlier, have not detected in influenza virions any capping and methylating enzymes active on the 5'-initiated termini of viral cRNA chains synthesized in vitro, whether these termini possess one, two, or three phosphates. Some mechanism for capping and methylation of viral cRNA must, however, exist, because the viral mRNA (cRNA) synthesized in the infected cell contains 5'-terminal methylated cap structures (Krug et al., J. Virol. 20:45-53, 1976). Possible mechanisms are discussed.
在镁离子(Mg(2+))和特定二核苷酸引物(ApG或GpG)存在的情况下,流感病毒粒子转录酶会合成包含多聚腺苷酸的八个离散互补RNA(cRNA)片段(普洛奇和克鲁格,《病毒学杂志》21:24 - 34,1977年)。对病毒粒子进行检测,以确定其对含有二磷酸或三磷酸化5'末端的cRNA进行加帽和甲基化的能力。通过使用引物ppApG、pppApG或ppGpG,以[α-(32)P]-GTP和S-[甲基-(3)H]腺苷甲硫氨酸作为标记前体,在体外合成病毒cRNA。对cRNA产物进行核糖核酸酶T2消化后的DEAE - 葡聚糖凝胶柱层析显示,完全没有(3)H掺入,且不存在(32)P标记的帽结构。由ppApG引发合成的cRNA的5'末端可以被痘苗病毒的酶加帽和甲基化,这表明来自引物的两个5'末端磷酸基团在产物cRNA中得以保留。痘苗病毒的酶形成的帽结构经核糖核酸酶T2消化后以m(7)GpppA(m)pGp形式释放,只有在转录过程中使用[α-(32)P]CTP作为标记前体时,其3'末端磷酸基团才会被放射性标记。这表明cRNA的5'末端序列是ppApGpC,因此,ppApG很可能恰好在病毒粒子RNA模板的3' GpCpU(OH)末端起始转录。还检测了病毒粒子在无转录情况下对ppApG进行加帽和甲基化的能力。未检测到此类活性,而在相同条件下,痘苗病毒的酶成功地对该化合物进行了加帽和甲基化。因此,这些实验以及早期报道的实验均未在流感病毒粒子中检测到对体外合成的病毒cRNA链的5'起始末端具有活性的任何加帽和甲基化酶,无论这些末端含有一个、两个还是三个磷酸基团。然而,病毒cRNA的加帽和甲基化机制必定存在,因为在受感染细胞中合成的病毒信使核糖核酸(cRNA)含有5'末端甲基化帽结构(克鲁格等人,《病毒学杂志》20:45 - 53,1976年)。文中讨论了可能的机制。